Similar articles

• An unexpected pathway for the metabolic degradation of 1,3-dialkyl-3-acyltriazenes.

  Rouzer CA, Thompson EJ, Skinner TL, Heavner PA, Bartolini WP, Mitchell K, Kurz E, Smith RH Jr, Michejda CJ. Rouzer CA, et al. Biochem Pharmacol. 1993 Jul 6;46(1):165-73. doi: 10.1016/0006-2952(93)90361-y. Biochem Pharmacol. 1993. PMID: 8347127
• 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.

  Carter SK, Friedman MA. Carter SK, et al. Eur J Cancer (1965). 1972 Feb;8(1):85-92. doi: 10.1016/0014-2964(72)90087-4. Eur J Cancer (1965). 1972. PMID: 4552317 Review. No abstract available.
• Oxidative metabolism of 1-(2-chloroethyl)-3-alkyl-3- (methylcarbamoyl)triazenes: formation of chloroacetaldehyde and relevance to biological activity.

  Rouzer CA, Sabourin M, Skinner TL, Thompson EJ, Wood TO, Chmurny GN, Klose JR, Roman JM, Smith RH Jr, Michejda CJ. Rouzer CA, et al. Chem Res Toxicol. 1996 Jan-Feb;9(1):172-8. doi: 10.1021/tx9500639. Chem Res Toxicol. 1996. PMID: 8924588
• Microsomal metabolism of triazenylimidazoles.

  Hill DL. Hill DL. Cancer Res. 1975 Nov;35(11 Pt 1):3106-10. Cancer Res. 1975. PMID: 241485
• Alkylating agents.

  Connors TA. Connors TA. Top Curr Chem. 1974;52:141-71. doi: 10.1007/3-540-06873-2_16. Top Curr Chem. 1974. PMID: 4617337 Review. No abstract available.